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Abstract Exocytosis of secretory granules by adrenal chromaffin cells is blocked by the tetanus toxin light chain in a zinc specific manner. Here 
we show that cellular synaptobrevin is almost completely degraded by the tetanus toxin light chain within 15 min. We used highly purified adrenal 
secretory granules to show that synaptobrevin, which can be cleaved by the tetanus toxin light chain, is localized in the vesicular membrane. Proteolysis 
of synaptobrevin i  cells and in secretory granules is reversibly inhibited by the zinc chelating agent dipicolinic acid. Moreover, cleavage of 
synaptobrevin present in secretory granules by the tetanus toxin light chain is blocked by the zinc peptidase inhibitor captopril and by synaptobrevin 
derived peptides. Our data indicate that the tetanus toxin light chain acts as a zinc dependent protease that cleaves ynaptobrevin of secretory granules, 
an essential component of the exocytosis machinery in adrenal chromaffin cells. 
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1. Introduction 
Tetanus and botulism are caused by clostridial neurotoxins 
which preferentially block transmitter release from glycinergic 
and cholinergic nerve terminals [1]. Recent observations indi- 
cate that these neurotoxins attack membrane proteins of synap- 
tic vesicles or of the presynaptic plasmalemma which are likely 
components of the docking/fusion complex in nerve endings 
[2-10]. Earlier investigations have shown that clostridial neuro- 
toxins also block exocytosis of secretory granules from adrenal 
chromaffin cells. Indeed the basic mechanisms of the neurotox- 
ins' action have first been detected in adrenal chromaffin cells 
[11-18] and have subsequently been confirmed in neurons [19- 
23]. From these studies it is evident hat the neurotoxins act 
intracellularly, that chain separation is a prerequisite for the 
inhibition of exocytosis by the light chains of the neurotoxins, 
and that they specifically block calcium triggered process(es) 
within the cascade of events leading to exocytosis. Recently, we 
identified the metal binding motif of the tetanus toxin light 
chain (TeTxL) as a key structure which mediates inhibition of 
exocytosis in adrenal chromaffin cells specifically when com- 
plexed with zinc [24]. Here we report that this action of the 
tetanus toxin light chain is due to the specific cleavage of syn- 
aptobrevin (SB) and identify synaptobrevin asan essential com- 
ponent of the exocytosis machinery of chromaffin cells. 
2. Experimental 
2.1. Materials 
2.1.1. Toxins, peptides and chemicals. Tetanus toxin was isolated 
and characterized aspreviously described [25,26]. During toxin purifi- 
cation EDTA (4 raM) was present in the first column step (HIC). 
Tetanus toxin was separated into its heavy and light chains by isoelec- 
tric focusing in a sucrose gradient with ampholyte under reducing 
conditions in 2 mol/1 urea [27]. Before use the purified tetanus toxin 
light chain (TeTxL) preparation was dialyzed against potassium gluta- 
mate medium (see below). Streptolysin O, used for controlled permea- 
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bilization of the chromaffin cells [28,29] was purified from group A 
streptococci (Richards train) by SH-specific hromatography followed 
by HIC chromatography (Weller et al. unpublished). 
The peptides QFET and ASQFETS were kindly prepared by 
J. Neckermann (Ulm, Germany) by solid phase synthesis using an 
automatic synthesizer (431A, pplied Biosystems, Foster City, 
CA, USA) employing F-moc chemistry. The peptides were detached 
with TFA from the resin, analyzed by HPLC on a Pep-S 5/zm column 
(Pharmacia, Freiburg, Germany) and characterized byEdman sequenc- 
ing (model 473 A sequenzer, Applied Biosystems, Foster City, 
CA, USA). Peptides 1 (DALQAGASVFESSAAKLKRK) and 2 
(DALQAGASQFETSAAKLKRK) were generous gifts from H. 
Niemann (Tiibingen, Germany). Captopril (3-mercapto-2-methylpro- 
pionyl-L-proline) was from Bristol-Myers Squibb (Miinchen, Ger- 
many). All other chemicals were of analytical grade. 
2.2. Methods 
2.2.1. Cultivation, permeabilization nd i cubation of chromaffin cells 
with TeTxL. Bovine adrenal chromaffin cells were isolated and grown 
as described [24] except that the cells were plated at a higher density 
(7 × 105 cells/well). After two days in culture the cells were p rmeabil- 
ized (at 30°C for 2 min) with streptolysin O (63 hemolytic units/well) 
in potassium glutamate medium (150 mM potassium glutamate, 10 mM 
PIPES (pH 7.2), 5 mM EDTA, 0.5 mM EGTA) containing 2 mM 
Mg~+-ATP, 7.67 mM magnesium acetate, 0.1% BSA and 1 mM dithio- 
threitol [24,29,30]. The medium was then replaced by the same medium 
containing TeTxL and/or the chemicals tobe tested, followed by incu- 
bation for 25 min at 30"C. Finally, the cells of each well were lyzed with 
100/11 SDS-sample buffer and proteins (determined with the BCA 
method, Pierce, Oud-Beijerland, Netherlands) were prepared for SDS- 
PAGE. 
2.2.2. Isolation of chromaffin vesicle membranes and incubation with 
TeTxL. Chromaffin vesicles were isolated as described [31,32]. Briefly, 
bovine adrenal glands were perfused with 5 mM HEPES (pH 7.0), 150 
mM NaCI, 5 mM EDTA. The medullae were homogenized in (20% w/v) 
20 mM MOPS (pH 7.0), 5 mM EDTA, 340 mM sucrose in a Teflon- 
to-glass homogenizer. From the postnuclear supernatant chromaffm 
vesicles were harvested by centrifugation for 20 min at 12,000 x g. They 
were placed on a discontinuous sucrose gradient consisting of 4 ml of 
2.4 M and 2 ml of each 2.2, 2.0, 1.8 and 1.6 M sucrose in 20 mM MOPS 
(pH 7.0), 5 mM EDTA. Centrifugation was done for 1 h at 40,000 rpm 
in a 50.2 Ti rotor (Beckman). Absorbance at280 nm after precipitation 
of the protein with 10% (w/v) TCA was measured toconveniently locate 
chromaffin vesicles in the gradient while arylsulfatase rved to identify 
fractions containing lysosomes and other subcellular membranes 
[31,32]. The chromaffin vesicles were recovered f om the gradient, di- 
luted 1:4 with 20 mM MOPS (pH 7.0), 5 mM EDTA and centrifuged 
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for 1 h at 100,000 x g. The purified chromaffm vesicles were osmotically 
lyzed by addition f a ten-fold excess of 20 mM MOPS (pH 7.0) with 
5 mM EDTA. Chromaffin vesicle membranes were recovered by cen- 
trifugation for 1 h at 100,000 x g and washed twice in potassium gluta- 
mate medium (see above) containing 6 mM magnesium acetate. The 
final pellet was suspended in the same medium and stored at -20°C 
until use. Chromaffin vesicle membranes (100 pg) were solubilized with 
0.5 mg of fl-o-octylglucopyranoside andincubated in a volume of 
50 gl for 30 min at 30°C in potassium glutamate medium (see above) 
containing 20 pmol TeTxL and/or the different chemicals to be tested. 
The reaction was stopped by cooling on ice, lipids were extracted by 
chloroform/methanol [33] and the samples were p ocessed for SDS- 
PAGE. 
2.2.3. Immunoblotting. The samples of chromaffin vesicle mem- 
branes or of chromaffin cells were separated by SDS-PAGE (12.5%) 
[34] and blotted onto nitrocellulose as described [35]. Binding of the 
monoclonal anti-synaptobrevin antibody (CI. 10.1; diluted I : 2,000) [36] 
or of the monoclonal anti-synaptotagmin I antibody (C1. 41.1; diluted 
1:2,000) [37] was detected insamples of chromaffin cells by peroxidase 
labelled anti-mouse IgG antibodies (Dianova, Hamburg) and the en- 
hanced chemiluminescence method (Amersham Buchler, Braun- 
schweig). For proteins prepared from chromaffin vesicle membranes, 
biotinylated anti-mouse IgG (Dianova, Hamburg) and avidin labelled 
peroxidase (Vectastain, Burlingame, CA, USA) and detection by DAB 
was employed. For controls we used a polyclonal neuron specific eno- 
lase (NSE) antibody (Dako Diagnostika, Hamburg, Germany). 
3.  Resu l t s  and  d i scuss ion  
Blockade of transmitter release from neurons by tetanus 
toxin is paralleled by the cleavage of synaptobrevin, a mem- 
brane protein of synaptic vesicles [2,3,6]. Exocytosis of 
hormone containing secretory granules i also inhibited by tet- 
anus toxin [12,13,15,16,38]. More recently we established the 
role of zinc and the HELIH motif of the tetanus toxin light 
chain (TeTxL) for the inhibition of calcium induced catechol- 
amine release from adrenal chromaffin cells [24]. Here we 
probed the functional significance of synaptobrevin for exocy- 
tosis of adrenal chromaffin cells using TeTxL as a tool. 
Synaptobrevin can readily be detected in immunoblots of 
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Fig. 1. Synaptobrevin cleavage within chromaffin cells by th  tetanus 
toxin light chain as a function of time. After permeabilization the cells 
were incubated for 5, 15 or 30 rain with 100 nM TeTxL at 30°C. The 
reaction was stopped by addition of SDS-sample buffer, followed by 
immunoblotting and synaptobrevin detection by the enhanced chemilu- 
minescence method. The lower panel shows almost complete disappear- 
ance of synaptobrevin (SB) with time of incubation. The upper panel 
displays the same blot after immunodetection of sy aptotagmin (ST), 
demonstrating the same amounts of samples in all lanes. 
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Fig. 2. Synaptobrevin cleavage within chromaflin cells by the tetanus 
toxin light chain depends o  zinc. As observed in immunoblots (lower 
panel), incubation f permeabilized chromaffin cells with 100 nM 
TeTxL results ina decrease of the synaptobrevin (SB) immunoreactive 
band. Addition of 100 pM dipicolinic acid (DPA) or of 1 mM captopril 
abolished this effect. The activity of TeTxL is restored after addition 
of 100 gM Zn 2+. The upper panel shows the control with anti-NSE. 
adrenal chromaffin cells. Within 15 min of incubation of perme- 
abilized chromaffin cells with TeTxL the synaptobrevin band 
of 18 kDa was greatly diminished and it was barely detectable 
after 30 min (Fig. 1, lower panel). In contrast, TeTxL treatment 
does not affect the electrophoretic mobility of other compo- 
nents of chromaffin cells such as synaptotagmin (ST) (Fig. 1, 
upper panel) or neuron specific enolase (NSE) (Fig. 2, upper 
panel). Moreover, we did not notice a change in the pattern of 
protein bands in Coomassie and silver stained gels of chro- 
maffin cells (not shown). Although this does not completely 
rule out that there may be TeTxL targets other than synapto- 
brevin [39,40], it is particularly intriguing that the specific 
degradation of synaptobrevin observed here and inhibition of 
exocytosis reported earlier [15,16,24] occured under identical 
conditions. 
Zinc can be removed from the catalytic site of TeTxL by 
dipicolinic acid (DPA) [41], a chelating agent with high affinity 
for zinc [42]. Concomitantly the inhibiton of secretory granule 
exocytosis by TetxL is abolished [24,41]. We found that synap- 
tobrevin cleavage within chromaffin cells is impaired by dipi- 
colinic acid (Fig. 2). Moreover, addition of zinc restored the 
activity of TeTxL (Fig. 2). Together these data suggest a causal 
link between zinc dependent cleavage of synaptobrevin by 
TeTxL and inhibition of exocytosis. The zinc peptidase inhibi- 
tor captopril and synaptobrevin derived peptides abolish the 
effect of TeTxL on neurotransmitter release and cleavage of 
synaptobrevin in isolated synaptic vesicles [2,3]. Moreover the 
inhibition of vasopressin release from neurohypophysial nerve 
terminals by TeTxL is blocked by these substances [41]. How- 
ever, neither synaptobrevin derived peptides nor captopril 
block the effect of TeTxL on catecholamine r lease by chro- 
maffin cells [24]. One could argue that breakdown of peptides 
and of the peptide derivative captopril by endogenous enzymes 
of chromaffin cells or absence of synaptobrevin from chro- 
maffin vesicle membranes [43,44] could account for these obser- 
vations. 
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Fig. 3. Sucrose density gradient fractionation of adrenal chromaffin 
vesicles. Chromaffm vesicles obtained by differential centrifugation 
were further purified on a discontinuous sucrose gradient (see section 
2). The fractions were collected from the bottom of the gradient. Ab- 
sorbance at 280 nm of the TCA supernatants, protein and the lysosomal 
enzyme arylsulfatase were measured. Chromaffin vesicles, marked by 
a bar, exhibit he highest density while lysosomes and other contaminat- 
ing organdies such as mitochondria [31,32] are found at lower sucrose 
densities. Synaptobrevin (immunoblot at bottom) was only found in 
chromaffin vesicle fractions. 
In order to clarify these issues, we first isolated adrenal chro- 
maffin vesicles by differential centrifugation and further puri- 
fied them in hyperosmotic sucrose gradients (see section 2). 
This procedure yields highly purified chromaffin vesicles with 
negligible contamination by lysosomes and other subcellular 
organelles [31,32]. As revealed by immunoblotting, the chro- 
maffin vesicle fractions of the gradient clearly do contain syn- 
aptobrevin (see Fig. 3). We then recovered chromaffin vesicles 
from the sucrose gradients, lyzed them hypotonically (see sec- 
tion 2) and used their membranes as a substrate for the tetanus 
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Fig. 4. Cleavage of synaptobrevin in chromat~ vesicle membranes by 
the tetanus toxin light chain depends on zinc. Chromaffm vesicle mem- 
branes (100/zg) were incubated for 30 min at 30°C with or without 20 
pmol tetanus toxin light c ain (TeTxL). Immunobiots revealed an al- 
most complete disappearance of the synaptobrevin (SB) immunoreac- 
tive band. Addition of 400 gmolar dipicolinic acid (DPA) abolished the 
effect of TeTxL. Reactivation ofTeTxL occurred with 400/zmolar zinc. 
Captopril (4 mM) prevented the cleavage of synaptobrevin byTeTxL. 
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Fig. 5. Effect of synaptobrevin derived peptides on the cleavage of 
synaptobrevin in chromaffm vesicle membranes by the tetanus toxin 
light chain. Incubation of chromattin vesicle membranes (100 pg) with 
20 pmol TeTxL caused an almost complete disappearance of synapto- 
brevin analyzed in immunoblots (C, only chromaffin vesicle membrans; 
1, with TeTxL). Peptides (400 gM) of different length ( 2, QFET; 3, 
ASQFETS; 4, peptide 1; 5, peptide 2) corresponding in sequence to the 
cleavage site of synaptobrevins (see section 2) abolished the effect of 
TeTxL on synaptobrevin degradation. 
toxin light chain (TeTxL). We first determined whether synap- 
tobrevin of chromaffin vesicle membranes i a substrate for 
TeTxL and whether the activity of the neurotoxin is blocked 
by DPA. This chelating agent has been shown to remove zinc 
from TeTxL [41], to abolish the inhibition of catecholamine 
release by TeTxL [24] and to block cleavage of synaptobrevin 
in chromaffin cells (see above). We found that TeTxL, within 
30 min of incubation at 30°C, almost completely removed im- 
munoreactive synaptobrevin from chromaffin vesicle mem- 
branes (Fig. 4). This effect was suppressed by DPA and was 
restored by zinc (Fig. 4). Furthermore, we found that the cleav- 
age of synaptobrevin by TeTxL was blocked by captopril, an 
inhibitor of zinc peptidases (Fig. 4). Finally, peptides panning 
the site of synaptobrevins cleaved by TeTxL in synaptic vesicles 
[2,3] were tested for an effect on synaptobrevin cleavage in 
chromaffin vesicle membranes. Both of the shorter peptides 
used (QFET and ASQFETS) and longer peptides (20-mers, see 
section 2) corresponding in sequence to synaptobrevin 1 and 
peptide 2 (a synaptobrevin 2 analogue) inhibited the cleavage 
of synaptobrevin i  chromaffin vesicle membranes (Fig. 5). 
Taken together our data indicate that TeTxL acts selectively 
as a zinc-dependent protease on synaptobrevin present in adre- 
nal chromaffin vesicle membranes. Thus, it can be concluded 
that secretory granules (this study) and synaptic vesicles [2,3,6], 
the storage organelles of neurotransmitters, neuropeptides and 
hormones, share the target of the tetanus toxin. This target, 
synaptobrevin, together withother membrane proteins and sol- 
uble proteins is a central component of a complex, which is 
critical for exocytosis [9,10]. 
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